aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $362.63 million. The enterprise value is $310.21 million.

Market Cap	362.63M
Enterprise Value	310.21M

Important Dates

The next estimated earnings date is Thursday, March 13, 2025, after market close.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 83.94 million shares outstanding. The number of shares has increased by 48.50% in one year.

Current Share Class	83.94M
Shares Outstanding	83.94M
Shares Change (YoY)	+48.50%
Shares Change (QoQ)	+4.87%
Owned by Insiders (%)	2.39%
Owned by Institutions (%)	60.52%
Float	77.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,543.11
Forward PS	n/a
PB Ratio	5.01
P/TBV Ratio	5.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,320.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.21.

Current Ratio	5.41
Quick Ratio	4.80
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.14% and return on invested capital (ROIC) is -44.28%.

Return on Equity (ROE)	-78.14%
Return on Assets (ROA)	-39.26%
Return on Invested Capital (ROIC)	-44.28%
Return on Capital Employed (ROCE)	-87.81%
Revenue Per Employee	$3,983
Profits Per Employee	-$1.08M
Employee Count	59
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +129.79% in the last 52 weeks. The beta is 1.11, so aTyr Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+129.79%
50-Day Moving Average	3.60
200-Day Moving Average	2.52
Relative Strength Index (RSI)	63.39
Average Volume (20 Days)	1,014,505

Short Selling Information

The latest short interest is 3.82 million, so 4.55% of the outstanding shares have been sold short.

Short Interest	3.82M
Short Previous Month	3.52M
Short % of Shares Out	4.55%
Short % of Float	4.95%
Short Ratio (days to cover)	1.47

Income Statement

In the last 12 months, aTyr Pharma had revenue of $235,000 and -$63.82 million in losses. Loss per share was -$0.93.

Revenue	235,000
Gross Profit	-54.66M
Operating Income	-68.05M
Pretax Income	-53.93M
Net Income	-63.82M
EBITDA	-67.35M
EBIT	-68.05M
Loss Per Share	-$0.93

Full Income Statement

Balance Sheet

The company has $65.99 million in cash and $13.57 million in debt, giving a net cash position of $52.42 million or $0.62 per share.

Cash & Cash Equivalents	65.99M
Total Debt	13.57M
Net Cash	52.42M
Net Cash Per Share	$0.62
Equity (Book Value)	65.14M
Book Value Per Share	0.86
Working Capital	62.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.05 million and capital expenditures -$57,000, giving a free cash flow of -$67.11 million.

Operating Cash Flow	-67.05M
Capital Expenditures	-57,000
Free Cash Flow	-67.11M
FCF Per Share	-$0.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-28,958.72%
Pretax Margin	-27,155.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.50%
Shareholder Yield	-48.50%
Earnings Yield	-17.60%
FCF Yield	-18.51%

Analyst Forecast

The average price target for aTyr Pharma is $18.60, which is 330.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.60
Price Target Difference	330.56%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	248.03%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	0.0714285:1

Scores

aTyr Pharma has an Altman Z-Score of -7.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.09
Piotroski F-Score	n/a